Search “best peptides for muscle growth” and you land in a marketplace of confident claims. This page does something the sales pages will not: it sorts the popular candidates by how much human evidence actually backs a gain in lean mass — and states plainly where that evidence runs out. The headline finding is uncomfortable for the category. None of these compounds is approved by any regulator for building muscle, and not one has a controlled trial showing it makes healthy, trained adults stronger.
The ranking principle
We grade on a single axis: published, controlled human data for a change in lean body mass or strength. Mechanistic plausibility and animal results sit far below that bar. By this standard the tiers below descend quickly, and the compound with the loudest reputation often sits near the bottom.
Tier 1 — The growth-hormone secretagogues (most-studied, smallest effect)
Sermorelin, the CJC-1295/ipamorelin pairing, and tesamorelin all work upstream: they prompt the pituitary to release more of your own growth hormone, which raises circulating IGF-1. That the IGF-1 needle moves is well documented. In hypogonadal men, a growth-hormone secretagogue regimen measurably increased serum IGF-1 over twelve months.[2]The catch is what that elevation buys you. Tesamorelin is the only molecule in this group with large placebo-controlled trials, and those trials were run for a specific medical problem — visceral fat accumulation in people with HIV. Pooled phase 3 data showed tesamorelin shrank deep abdominal fat versus placebo,[3] with the clearest responses in patients who had higher baseline IGF-1 and triglycerides.[4] What those studies did not show is a meaningful, durable jump in lean mass or any gain in measured strength. Sermorelin and CJC-1295/ipamorelin have thinner human records still — mostly IGF-1 and short-term body-composition signals, not strength trials. So the most-studied peptides here earn the top tier only on volume of data; the size of the muscle effect is modest at best.
Tier 2 — MK-677 / ibutamoren (one good trial, telling result)
MK-677 is an orally active ghrelin-mimetic that raises GH and IGF-1 without an injection, which is why bodybuilding forums treat it as a near-anabolic. It does have a clean piece of evidence: a randomized trial in healthy older adults found that MK-677 increased fat-free mass over a year.[1] Read the fine print, though. That increase was driven substantially by water retention, the trial did not demonstrate gains in muscle strength or function, and side effects included rising blood glucose and fluid-related symptoms. It is the best single result in the muscle-peptide space — and it still falls short of “builds muscle that performs.”
Tier 3 — IGF-1 LR3 (potent in theory, untested and risky in people)
IGF-1 LR3 is a modified, long-acting version of insulin-like growth factor 1 — the very hormone the Tier 1 compounds try to coax your body into making. On paper it is the most directly anabolic option on this list, which is exactly why it sits low: there are no controlled human trials of IGF-1 LR3 for muscle building, and deliberately flooding the body with a growth factor that acts on nearly every tissue carries real concerns, including the theoretical promotion of abnormal cell growth. Potency without human safety data is not a recommendation.
Tier 4 — BPC-157 and TB-500 (recovery stories, animal-only)
These two are usually sold for repair and recovery rather than hypertrophy, and people fold them into “muscle” stacks on the logic that faster healing means more training. The biology is interesting in rodents: BPC-157 has been shown to upregulate growth-hormone receptor expression in tendon fibroblasts in culture,[5] and thymosin beta-4 — the parent molecule of TB-500 — has documented roles in angiogenesis and tissue repair.[6] But the human ledger is essentially empty. There are no controlled trials in people showing either compound speeds muscle recovery or adds lean mass. Lowest tier, for the honest reason that the evidence is preclinical.
What GH and IGF-1 manipulation actually does to a physique
It is worth stepping back from the molecule names to the shared mechanism. Almost everything in Tiers 1 through 3 works by pushing the GH/IGF-1 system. In the populations where that has been studied properly, the effect is a modest shift in body composition — less visceral fat, a little more fat-free mass that is partly fluid — not the dramatic, strength-bearing muscle gain the category implies. And the manipulation is not free: elevated GH/IGF-1 signaling is associated with fluid retention, joint discomfort, insulin resistance, and rising blood sugar, exactly the side-effect pattern seen in the MK-677 trial.[1] Modest upside, real downside, no approval for this use.
What the evidence actually supports
Here is the part the rankings keep pointing back to. The intervention with the strongest, most reproducible human evidence for adding muscle is not a peptide at all. A meta-analysis pooling dozens of trials confirmed that resistance training combined with adequate protein intake reliably increases muscle mass and strength in healthy adults.[7]That effect dwarfs anything demonstrated for the compounds above. For someone whose own hormones are clinically low, a physician-supervised therapy such as testosterone has a far deeper evidence base than any peptide and is the appropriate medical route — not a research chemical bought online.
The verdict: if a peptide belongs anywhere in a muscle-growth conversation, the tesamorelin and MK-677 data are the only human signals worth naming, and even those describe a modest body-composition shift in clinical populations rather than performance gains in healthy lifters. Sermorelin and CJC-1295/ipamorelin ride mostly on IGF-1 numbers, IGF-1 LR3 is untested and risky in people, and BPC-157 and TB-500 remain animal stories. Rank them honestly and the tallest bar belongs to training, protein, and — where genuinely indicated — medically supervised hormone therapy. Everything else is a research compound asking you to act on evidence that does not yet exist.
